Increased activity of the PI3K/AKT/mTOR signaling pathway, which is a common event in HCC affecting ≈50% of tumors, has been correlated with poor prognosis, early recurrence, and reduced OS [129]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.